Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Advaxis - Stock Price History | ADXS

Historical daily share price chart and data for Advaxis since 2020 adjusted for splits. The latest closing stock price for Advaxis as of August 07, 2020 is 0.55.
  • The all-time high Advaxis stock closing price was 62.50 on July 29, 2005.
  • The Advaxis 52-week high stock price is 1.48, which is 169.1% above the current share price.
  • The Advaxis 52-week low stock price is 0.21, which is 61.8% below the current share price.
  • The average Advaxis stock price for the last 52 weeks is 0.61.
  
Advaxis Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.1949 0.2950 6.5100 0.2485 0.8577 351.42%
2018 1.4992 3.1000 3.2400 0.1855 0.1900 -93.31%
2017 6.4869 7.4900 9.6000 2.8200 2.8400 -60.34%
2016 8.9600 9.4100 15.9800 5.4600 7.1600 -28.83%
2015 14.7490 8.4200 28.7700 7.0200 10.0600 25.59%
2014 3.6215 4.0800 9.0000 2.5100 8.0100 88.92%
2013 6.5045 3.7500 17.5000 2.7000 4.2400 13.07%
2012 11.6800 20.0000 21.2500 3.7500 3.7500 -81.25%
2011 18.6210 15.0000 30.0000 15.0000 20.0000 33.33%
2010 19.6726 16.2500 28.7500 12.5000 15.0000 -14.29%
2009 10.6448 2.5000 21.2500 2.5000 17.5000 600.00%
2008 10.1117 21.2500 21.2500 1.6250 2.5000 -88.24%
2007 28.6653 25.0000 53.7500 17.5000 21.2500 -5.56%
2006 27.1365 26.2500 37.5000 17.5000 22.5000 -14.29%
2005 30.7913 56.2500 62.5000 20.0000 26.2500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.034B $0.021B
Advaxis, Inc. is a development stage biotechnology company focused on developing safe and effective cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence containing a tumor-specific antigen. The Company believes this vaccine technology is capable of stimulating the body's immune system to process and recognize the antigen as if it were foreign, generating an immune response able to attack the cancer. It also considers this to be a broadly enabling platform technology that can be applied to the treatment of many types of cancers, infectious diseases and auto-immune disorders. The Company's products in development include Lovaxin C and Lovaxin B, Lovaxin P.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.971B 15.31
Bristol Myers Squibb (BMY) United States $138.069B 10.63
CSL (CSLLY) Australia $89.402B 0.00
Gilead Sciences (GILD) United States $86.991B 12.52
Vertex Pharmaceuticals (VRTX) United States $71.105B 39.68
Regeneron Pharmaceuticals (REGN) United States $68.234B 25.23
Illumina (ILMN) United States $52.282B 60.38
Biogen (BIIB) United States $48.398B 8.28
Seattle Genetics (SGEN) United States $27.918B 0.00
Moderna (MRNA) United States $27.508B 0.00
Genmab (GMAB) Denmark $23.865B 19.63
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.603B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.636B 9.43
Genmab (GNMSF) Denmark $22.579B 67.03
BioMarin Pharmaceutical (BMRN) United States $21.521B 156.14
Incyte (INCY) United States $21.198B 0.00
BeiGene (BGNE) Cayman Islands $19.703B 0.00
BioNTech SE (BNTX) Germany $17.422B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.557B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.703B 36.74
Bio-Rad Laboratories (BIO.B) United States $15.581B 70.47
Exact Sciences (EXAS) United States $13.018B 0.00
Sarepta Therapeutics (SRPT) United States $12.480B 0.00
Galapagos (GLPG) Belgium $12.446B 36.61
ARGENX SE-ADR (ARGX) Netherlands $10.848B 0.00
QIAGEN (QGEN) Netherlands $10.775B 27.35
Bio-Techne Corp (TECH) United States $10.158B 70.31
Immunomedics (IMMU) United States $9.928B 0.00
Novavax (NVAX) United States $9.870B 0.00
Guardant Health (GH) United States $8.097B 0.00
Repligen (RGEN) United States $8.021B 127.31
Ascendis Pharma (ASND) Denmark $7.714B 0.00
Emergent Biosolutions (EBS) United States $6.915B 27.39
Exelixis (EXEL) United States $6.857B 25.12
ACADIA Pharmaceuticals (ACAD) United States $6.660B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.302B 195.24
SWEDISH ORP BIO (BIOVF) Sweden $6.177B 15.37
Vir Biotechnology (VIR) United States $6.134B 0.00
Mirati Therapeutics (MRTX) United States $5.625B 0.00
MyoKardia (MYOK) United States $5.481B 0.00
Acceleron Pharma (XLRN) United States $5.335B 0.00
Reata Pharmaceuticals (RETA) United States $5.192B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.140B 0.00
Adaptive Biotechnologies (ADPT) United States $4.901B 0.00
Zai Lab (ZLAB) China $4.669B 0.00
NeoGenomics (NEO) United States $4.382B 1322.67
Bluebird Bio (BLUE) United States $4.204B 0.00
China Biologic Products (CBPO) China $4.176B 23.21
Blueprint Medicines (BPMC) United States $4.115B 0.00
MorphoSys AG (MOR) Germany $4.105B 53.79
Amicus Therapeutics (FOLD) United States $3.971B 0.00
Halozyme Therapeutics (HALO) United States $3.935B 0.00
Global Blood Therapeutics (GBT) United States $3.916B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.883B 0.00
Arena Pharmaceuticals (ARNA) United States $3.647B 0.00
Sorrento Therapeutics (SRNE) United States $3.490B 0.00
Denali Therapeutics (DNLI) United States $3.339B 0.00
Inovio Pharmaceuticals (INO) United States $3.197B 0.00
Insmed (INSM) United States $3.106B 0.00
Principia Biopharma (PRNB) United States $3.036B 0.00
Alkermes (ALKS) Ireland $2.973B 62.32
Fate Therapeutics (FATE) United States $2.938B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.757B 0.00
Amarin (AMRN) Ireland $2.698B 0.00
Twist Bioscience (TWST) United States $2.527B 0.00
Editas Medicine (EDIT) United States $1.917B 0.00
PHARMA MAR SA (PHMMF) Spain $1.908B 0.00
Viela Bio (VIE) United States $1.902B 0.00
Ligand Pharmaceuticals (LGND) United States $1.888B 63.95
Mesoblast (MESO) Australia $1.874B 0.00
UniQure (QURE) Netherlands $1.836B 0.00
Sangamo Therapeutics (SGMO) United States $1.738B 0.00
I-Mab (IMAB) China $1.716B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.682B 40.04
Intercept Pharmaceuticals (ICPT) United States $1.606B 0.00
Eidos Therapeutics (EIDX) United States $1.590B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.554B 0.00
Revance Therapeutics (RVNC) United States $1.487B 0.00
Adverum Biotechnologies (ADVM) United States $1.482B 0.00
Zymeworks (ZYME) Canada $1.408B 0.00
Coherus BioSciences (CHRS) United States $1.392B 8.18
Intra-Cellular Therapies (ITCI) United States $1.389B 0.00
Zealand Pharma (ZEAL) Denmark $1.371B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.362B 0.00
Mersana Therapeutics (MRSN) United States $1.357B 0.00
Epizyme (EPZM) United States $1.306B 0.00
NGM Biopharmaceuticals (NGM) United States $1.289B 0.00
Cytokineticsorporated (CYTK) United States $1.279B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
REGENXBIO (RGNX) United States $1.230B 0.00
Beam Therapeutics (BEAM) United States $1.208B 0.00
Alcobra (ARCT) United States $1.185B 0.00
Akcea Therapeutics (AKCA) United States $1.179B 0.00
Alector (ALEC) United States $1.174B 0.00
Arvinas (ARVN) United States $1.127B 0.00
Compugen (CGEN) Israel $1.117B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.051B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.038B 0.00
NantKwest (NK) United States $1.036B 0.00
Intellia Therapeutics (NTLA) United States $1.019B 0.00
Arcus Biosciences (RCUS) United States $1.002B 0.00
Heska (HSKA) United States $0.986B 0.00
VBI Vaccines (VBIV) United States $0.981B 0.00
Retrophin (RTRX) United States $0.977B 0.00
Myriad Genetics (MYGN) United States $0.909B 46.88
Athenex (ATNX) United States $0.899B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.860B 0.00
Intrexon (PGEN) United States $0.840B 0.00
Codexis (CDXS) United States $0.812B 0.00
Cara Therapeutics (CARA) United States $0.793B 0.00
Morphic Holding (MORF) United States $0.778B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
Cellectis S.A (CLLS) France $0.743B 0.00
Castle Biosciences (CSTL) United States $0.720B 0.00
Dynavax Technologies (DVAX) United States $0.717B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.711B 0.00
Vericel (VCEL) United States $0.710B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.704B 0.00
Kadmon Holdings (KDMN) United States $0.680B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
MiMedx (MDXG) United States $0.663B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.655B 5.74
Agenus (AGEN) United States $0.643B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.572B 0.00
Cue Biopharma (CUE) United States $0.565B 0.00
Syros Pharmaceuticals (SYRS) United States $0.557B 0.00
MeiraGTx Holdings (MGTX) United States $0.516B 0.00
Athersys (ATHX) United States $0.515B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
AnaptysBio (ANAB) United States $0.504B 0.00
Protagonist Therapeutics (PTGX) United States $0.493B 0.00
Anika Therapeutics (ANIK) United States $0.489B 21.41
Kala Pharmaceuticals (KALA) United States $0.487B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Innate Pharma S.A (IPHA) France $0.471B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.459B 0.00
Cel-Sci (CVM) United States $0.459B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.456B 0.00
AC Immune SA (ACIU) Switzerland $0.454B 0.00
BioDelivery Sciences (BDSI) United States $0.453B 32.07
IBio (IBIO) United States $0.450B 0.00
Prometic Life Sciences (LMNL) Canada $0.437B 0.00
Avid Bioservices (CDMO) United States $0.437B 0.00
Scholar Rock Holding (SRRK) United States $0.420B 0.00
Clovis Oncology (CLVS) United States $0.417B 0.00
Puma Biotechnology (PBYI) United States $0.404B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.392B 0.00
Kamada (KMDA) Israel $0.387B 16.11
Merus (MRUS) Netherlands $0.385B 0.00
ANI Pharmaceuticals (ANIP) United States $0.374B 8.83
Albireo Pharma (ALBO) United States $0.372B 0.00
MannKind (MNKD) United States $0.364B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
PDL BioPharma (PDLI) United States $0.360B 0.00
Precision BioSciences (DTIL) United States $0.359B 0.00
Seres Therapeutics (MCRB) United States $0.354B 0.00
CytomX Therapeutics (CTMX) United States $0.350B 0.00
Geron (GERN) United States $0.342B 0.00
WAVE Life Sciences (WVE) Singapore $0.327B 0.00
Biofrontera AG (BFRA) Germany $0.326B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.311B 0.00
ChromaDex (CDXC) United States $0.306B 0.00
Starpharma Holdings (SPHRY) Australia $0.293B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Pfenex (PFNX) United States $0.284B 0.00
OSMOTICA PHARM (OSMT) United States $0.284B 0.00
Cellular Biomedicine (CBMG) United States $0.280B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.279B 0.00
Menlo Therapeutics (MNLO) United States $0.271B 0.00
Spero Therapeutics (SPRO) United States $0.267B 0.00
NextCure (NXTC) United States $0.263B 0.00
Arbutus Biopharma (ABUS) United States $0.262B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
Trevena (TRVN) United States $0.255B 0.00
Fortress Biotech (FBIO) United States $0.252B 0.00
Celldex Therapeutics (CLDX) United States $0.251B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
DBV Technologies S.A (DBVT) France $0.248B 0.00
Dyadic (DYAI) United States $0.244B 0.00
Verastem (VSTM) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.235B 0.00
Selecta Biosciences (SELB) United States $0.232B 0.00
Pluristem Therapeutics (PSTI) Israel $0.229B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.228B 0.00
IVERIC Bio (ISEE) United States $0.227B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Exicure (XCUR) United States $0.209B 0.00
Aduro Biotech (ADRO) United States $0.207B 0.00
Five Prime Therapeutics (FPRX) United States $0.206B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.198B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.197B 9.20
GENFIT S.A (GNFT) France $0.193B 0.00
Theratechnologies (THTX) Canada $0.189B 0.00
XOMA (XOMA) United States $0.181B 0.00
Aptinyx (APTX) United States $0.180B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Liquidia Technologies (LQDA) United States $0.176B 0.00
Cerecor (CERC) United States $0.169B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Bellus Health (BLU) Canada $0.166B 0.00
Kindred Biosciences (KIN) United States $0.165B 0.00
VTv Therapeutics (VTVT) United States $0.165B 0.00
Cidara Therapeutics (CDTX) United States $0.160B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Cyclerion Therapeutics (CYCN) United States $0.148B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Applied Genetic Technologies (AGTC) United States $0.142B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.139B 0.00
Gritstone Oncology (GRTS) United States $0.139B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Palatin Technologies (PTN) United States $0.128B 3.29
Checkpoint Therapeutics (CKPT) United States $0.127B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
Lumos Pharma (LUMO) United States $0.125B 0.00
Orgenesis (ORGS) United States $0.123B 6.29
Cardiff Oncology (CRDF) United States $0.122B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
Oncobiologics (OTLK) United States $0.119B 0.00
PHASEBIO PHARMA (PHAS) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
CorMedix Inc (CRMD) United States $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.106B 0.00
Antibe Therapeutics (ATBPF) Canada $0.103B 0.00
Vaccinex (VCNX) United States $0.099B 0.00
ARAVIVE, INC (ARAV) United States $0.097B 0.00
Organovo Holdings (ONVO) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Unum Therapeutics (UMRX) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.081B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
DiaMedica Therapeutics (DMAC) United States $0.077B 0.00
Ecology Coatings (ABVC) United States $0.074B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.074B 0.00
Bionano Genomics (BNGO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
Synlogic (SYBX) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.067B 96.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Soligenix (SNGX) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
IMMURON (IMRN) Australia $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.060B 0.00
Genetic Technologies (GENE) Australia $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
Curis (CRIS) United States $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Novogen (KZIA) Australia $0.046B 0.00
Spherix (AIKI) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Celsion (CLSN) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Prana Biotechnology (ATHE) Australia $0.037B 0.00
OvaScience (MLND) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Forte Biosciences (FBRX) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Cleveland BioLabs (CBLI) United States $0.032B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Chanticleer Holdings (SONN) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
MYOS RENS Technology (MYOS) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
BioCardia (BCDA) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00